Zimbabwe has turned down a substantial US healthcare agreement worth 367 million US dollars (£272m) spanning five years because of Washington's insistence on confidential biological samples.
The decision became public after a government memo from December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "skewed".
A government representative has since stated that the US was demanding access to health data for scientific study and profit while refused to guarantee the benefits from future treatments.
"We are forced to start the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had donated over $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for continued talks to reach a agreement suitable to both sides so the country's critical HIV treatment initiative can be sustained.
Wider Context
This development comes after a similar case in Kenya, where a court suspended a similar deal with the US after legal challenges were filed about the security of Kenyans' health data.
After returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered aid for the American government, but Trump claimed its spending was "inefficient" and his government was pursuing direct bilateral deals to enhance openness and responsibility.
According to reports, 16 African countries have so far signed these new agreements, representing more than $18.3bn in new funding.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration might have yielded immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving HIV treatment through American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, without any corresponding assurance of access to any scientific breakthroughs – like new medicines or tests – that could result from that provided information," he stated.
"Put simply, our nation would supply the basic resources for scientific discovery with no certainty that the final treatments would be available to our citizens should a new pandemic arise."
Sovereignty and International Frameworks
Mangwana further noted that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting structures previously established via the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to manage potential pandemics.
"This framework is intended to guarantee that when a country contributes its data, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome further dialogue with our American counterparts on how subsequent co-operation could be arranged in a manner that respects the independence and interests of both nations."
Medical Community Reaction
Medical experts stated it acknowledged the official position, but recommended that negotiations should continue given that a large portion of the nation's Aids initiatives were funded by external financing.
"If specific concerns arise, including those relating to data governance or agreement terms, these can often be addressed via detailed discussion and negotiated safeguards," the group said.
The situation highlights the continuing tensions between receiving vital foreign assistance and protecting a country's data in an increasingly interconnected world.